ICICI Prudential Nifty Pharma Index Fund Direct - Idcw

  • 3 Months
  • 6 Months
  • 1 Year
  • 3 Years
  • 5 Years
  • RSI
3 Months Returns : 0.71%
NAV: ₹17.47 as on Tue Nov 25, 2025
Fund NAV

Fund Overview of ICICI Prudential Nifty Pharma Index Fund Direct - Idcw

  • ₹94.9 Cr
    AUM
  • ₹17.47
    NAV
  • 0.37%
    Expense Ratio
  • Equity
    Fund Category
As on Tue Nov 25, 2025

Returns of ICICI Prudential Nifty Pharma Index Fund Direct - Idcw

Tenure Absolute(%) Annualised(%) Category Average(%)
3 Months 0.71% NA 6.12%
6 Months 11.47% NA 12.92%
1 Year -4.33% -4.33% 6.04%
2 Years 47.09% 21.28% 24.93%
As on Tue Nov 25, 2025

Asset Allocation

equities

99.98%

other assets or cash equivalents

0.02%
Large Cap: 69.38%
Mid Cap: 24.15%
Small Cap: 6.47%
Other: 0.00%
Top Holdings
Sun Pharmaceutical Industries Ltd
22.49%
Sun Pharmaceutical Industries Ltd
22.18%
Sun Pharmaceutical Industries Ltd
22.18%
Sun Pharmaceutical Industries Ltd
21.61%
Cipla Ltd
10.69%
 
Top Sectors
Healthcare
399.71%
Unspecified
0.29%
Detailed Portfolio Analysis
As on Tue Nov 25, 2025
Invest Now

About Fund

About ICICI Prudential Nifty Pharma Index Fund Direct - Idcw

ICICI Prudential Nifty Pharma Index Fund Direct - Idcw is one Equity mutual fund offered by ICICI Prudential Mutual Fund. Launched on 14 Dec 2022, the fund aims Long term wealth creation solution. An index fund that seeks to track returns by investing in a basket of Nifty Pharma Index stocks and aims to achieve returns of the stated index, subject to tracking error. It manages assets worth ₹94.9 crore as on Thu Jul 31, 2025. The expense ratio stands at 0.37%.
The portfolio allocation consists of 99.98% in equities, 0.02% in other assets or cash equivalents. Managed by Nishit Patel, it has delivered a return of -4.33% in the last year, a total return since inception of 21.13%.

Read more
  • Ashwini Shinde

    Fund Manager

  • B.Com , M.Com , Inter CA

    Manager Education

  • Kayzad Eghlim

    Fund Manager

  • Mr. Eghlim is a B.Com (H) and M Com.

    Manager Education

  • Nishit Patel

    Fund Manager

  • Mr. Patel is a B.Com & Chartered Accountant

    Manager Education

Fund Details

Fund Names ICICI Prudential Nifty Pharma Index Fund Direct - Idcw
Inception Date 14 Dec 2022
Lock In No Lock-in
SIP Minimum Investment amount ₹ 1000
SWP Minimum Investment amount ₹ 1
STP Minimum Investment amount ₹ 250
 
Risk Principal at very high risk
Category Average Annual Returns 6.04
More Details
Highest NAV in last 52 weeks & Lowest NAV in last 52 weeks

Top Performing Mutual Funds

Fund Names AUM (Cr) 1M 3M 1Yr 3Yr 5Yr
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth trend ₹6,104 -0.73% -1.14% 6.20% 28.02% 21.10%
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth trend ₹6,104 -0.79% -1.33% 5.36% 26.93% 20.05%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth trend ₹872 -0.20% -1.78% 1.78% 22.39% 17.07%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth trend ₹872 -0.32% -2.11% 0.45% 20.74% 15.41%
increase growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns

More funds from ICICI Prudential Mutual Fund

Fund Names AUM (Cr) 1M 3M 6M 1Yr 3Yr
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth increase ₹6,104 -0.79% -1.33% 4.95% 5.36% 26.93%
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth increase ₹6,104 -0.73% -1.14% 5.37% 6.20% 28.02%
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw increase ₹6,104 -0.79% -1.33% 4.95% 5.36% 26.93%
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw increase ₹6,104 -0.73% -1.14% 5.37% 6.20% 28.02%
ICICI Prudential Nifty Healthcare Etf - Growth increase ₹146 -0.43% 0.31% 6.23% 5.45% 21.89%
ICICI Prudential Nifty Pharma Index Fund - Growth increase ₹95 0.97% 0.73% 5.31% 1.63% -
ICICI Prudential Nifty Pharma Index Fund Direct - Growth increase ₹95 1.02% 0.88% 5.64% 2.23% -
ICICI Prudential Nifty Pharma Index Fund - Idcw increase ₹95 0.97% 0.73% 5.31% 1.63% -
View More
increase growth is based on 1-month returns of the funds

Mutual Fund Calculator

I want to invest Pro Tip
Financial experts suggest that a person should invest 10-15% of their monthly income for long-term financial growth
/Month
I want to invest for Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 29
  • 31
  • 32
  • 33
  • 34
  • 36
  • 37
  • 38
  • 39
  • 40
Expected return Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 30
Total Investment
Wealth Gained
Total Wealth
Start Investing
I want to save
I want to invest for Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 29
  • 31
  • 32
  • 33
  • 34
  • 36
  • 37
  • 38
  • 39
  • 40
Expected return Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 11
  • 12
  • 13
  • 14
  • 16
  • 17
  • 18
  • 19
  • 21
  • 22
  • 23
  • 24
  • 26
  • 27
  • 28
  • 30
Total Investment
Wealth Gained
Monthly Investment
Invest Now
You can also get Tax Free Maturity/ Returns? You can also get Tax Free Maturity/ Returns?

Top Mutual Funds

Fund Names AUM (Cr) NAV 3Yr 5Yr 10Yr
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth trend ₹6,104 ₹40.11 26.93% 20.05% -
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth trend ₹6,104 ₹43.33 28.02% 21.10% -
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth trend ₹872 ₹34.25 22.39% 17.07% -
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth trend ₹872 ₹31.05 20.74% 15.41% -
ICICI Prudential Nifty Healthcare Etf - Growth trend ₹146 ₹151.38 21.89% - -
Aditya Birla Sun Life Nifty Healthcare Etf-growth trend ₹37 ₹15.18 22.06% - -
View More
Top funds are based on Fund AUM

Detailed Portfolio

Stocks Sector % of Holding Value
Sun Pharmaceutical Industries LtdHealthcare22.49%₹21.33 Cr
Sun Pharmaceutical Industries LtdHealthcare22.18%₹20.14 Cr
Sun Pharmaceutical Industries LtdHealthcare22.18%₹20.14 Cr
Sun Pharmaceutical Industries LtdHealthcare21.61%₹19.03 Cr
Cipla LtdHealthcare10.69%₹10.14 Cr
Divi's Laboratories LtdHealthcare10.24%₹9.71 Cr
Divi's Laboratories LtdHealthcare10.66%₹9.68 Cr
Divi's Laboratories LtdHealthcare10.66%₹9.68 Cr
Cipla LtdHealthcare10.88%₹9.58 Cr
Cipla LtdHealthcare10.51%₹9.55 Cr
Cipla LtdHealthcare10.51%₹9.55 Cr
Dr. Reddy's Laboratories LtdHealthcare9.45%₹8.97 Cr
Dr. Reddy's Laboratories LtdHealthcare9.59%₹8.45 Cr
Dr. Reddy's Laboratories LtdHealthcare9.08%₹8.25 Cr
Dr. Reddy's Laboratories LtdHealthcare9.08%₹8.25 Cr
Divi's Laboratories LtdHealthcare9.30%₹8.19 Cr
Lupin LtdHealthcare5.70%₹5.41 Cr
Lupin LtdHealthcare5.91%₹5.37 Cr
Lupin LtdHealthcare5.91%₹5.37 Cr
Lupin LtdHealthcare5.95%₹5.24 Cr
Torrent Pharmaceuticals LtdHealthcare4.78%₹4.54 Cr
Torrent Pharmaceuticals LtdHealthcare4.85%₹4.27 Cr
Torrent Pharmaceuticals LtdHealthcare4.64%₹4.21 Cr
Torrent Pharmaceuticals LtdHealthcare4.64%₹4.21 Cr
Laurus Labs LtdHealthcare4.61%₹4.19 Cr
Laurus Labs LtdHealthcare4.61%₹4.19 Cr
Laurus Labs LtdHealthcare4.18%₹3.97 Cr
Glenmark Pharmaceuticals LtdHealthcare3.93%₹3.73 Cr
Laurus Labs LtdHealthcare4.21%₹3.71 Cr
Aurobindo Pharma LtdHealthcare3.90%₹3.70 Cr
Aurobindo Pharma LtdHealthcare3.97%₹3.60 Cr
Aurobindo Pharma LtdHealthcare3.97%₹3.60 Cr
Alkem Laboratories LtdHealthcare3.86%₹3.51 Cr
Alkem Laboratories LtdHealthcare3.86%₹3.51 Cr
Alkem Laboratories LtdHealthcare3.93%₹3.46 Cr
Aurobindo Pharma LtdHealthcare3.90%₹3.43 Cr
Mankind Pharma Ltd.Healthcare3.54%₹3.36 Cr
Glenmark Pharmaceuticals LtdHealthcare3.78%₹3.33 Cr
Glenmark Pharmaceuticals LtdHealthcare3.55%₹3.22 Cr
Glenmark Pharmaceuticals LtdHealthcare3.55%₹3.22 Cr
Alkem Laboratories LtdHealthcare3.31%₹3.14 Cr
Mankind Pharma Ltd.Healthcare3.54%₹3.12 Cr
Mankind Pharma Ltd.Healthcare3.36%₹3.05 Cr
Mankind Pharma Ltd.Healthcare3.36%₹3.05 Cr
Zydus Lifesciences LtdHealthcare2.96%₹2.81 Cr
Zydus Lifesciences LtdHealthcare3.16%₹2.78 Cr
Zydus Lifesciences LtdHealthcare3.03%₹2.75 Cr
Zydus Lifesciences LtdHealthcare3.03%₹2.75 Cr
Biocon LtdHealthcare2.87%₹2.73 Cr
Biocon LtdHealthcare2.78%₹2.53 Cr
Biocon LtdHealthcare2.78%₹2.53 Cr
Ipca Laboratories LtdHealthcare2.50%₹2.37 Cr
Biocon LtdHealthcare2.63%₹2.32 Cr
Ipca Laboratories LtdHealthcare2.39%₹2.11 Cr
Abbott India LtdHealthcare2.19%₹2.08 Cr
Ipca Laboratories LtdHealthcare2.20%₹2.00 Cr
Ipca Laboratories LtdHealthcare2.20%₹2.00 Cr
Gland Pharma LtdHealthcare2.01%₹1.90 Cr
Gland Pharma LtdHealthcare2.04%₹1.80 Cr
Gland Pharma LtdHealthcare1.91%₹1.74 Cr
Gland Pharma LtdHealthcare1.91%₹1.74 Cr
Abbott India LtdHealthcare1.96%₹1.73 Cr
Abbott India LtdHealthcare1.89%₹1.71 Cr
Abbott India LtdHealthcare1.89%₹1.71 Cr
Jb Chemicals & Pharmaceuticals LtdHealthcare1.75%₹1.66 Cr
Jb Chemicals & Pharmaceuticals LtdHealthcare1.79%₹1.58 Cr
Jb Chemicals & Pharmaceuticals LtdHealthcare1.71%₹1.55 Cr
Jb Chemicals & Pharmaceuticals LtdHealthcare1.71%₹1.55 Cr
Wockhardt LtdHealthcare1.61%₹1.42 Cr
Piramal Pharma LtdHealthcare1.54%₹1.39 Cr
Piramal Pharma LtdHealthcare1.54%₹1.39 Cr
Ajanta Pharma LtdHealthcare1.41%₹1.34 Cr
Piramal Pharma LtdHealthcare1.52%₹1.34 Cr
Wockhardt LtdHealthcare1.32%₹1.20 Cr
Wockhardt LtdHealthcare1.32%₹1.20 Cr
Ajanta Pharma LtdHealthcare1.29%₹1.17 Cr
Ajanta Pharma LtdHealthcare1.29%₹1.17 Cr
Ajanta Pharma LtdHealthcare1.30%₹1.15 Cr
Natco Pharma LtdHealthcare1.04%₹0.99 Cr
Granules India LtdHealthcare0.84%₹0.80 Cr
RepoUnspecified0.87%₹0.77 Cr
RepoUnspecified0.67%₹0.61 Cr
RepoUnspecified0.67%₹0.61 Cr
RepoUnspecified0.16%₹0.15 Cr
Net Current AssetsUnspecified0.04%₹0.04 Cr
Net PayablesUnspecified-0.65%₹-0.59 Cr
Net PayablesUnspecified-0.65%₹-0.59 Cr
Net PayablesUnspecified-0.82%₹-0.72 Cr
View More

Top Equity Funds

Fund Names NAV 3Yr 5Yr 52 weeks high
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth increase ₹43.33 28.02% 21.10% 44.69
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth increase ₹40.11 26.93% 20.05% 41.47
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth increase ₹34.25 22.39% 17.07% -
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth increase ₹31.05 20.74% 15.41% -
increase growth is based on 5Y returns of the funds

Frequently Asked Questions

ICICI Prudential Nifty Pharma Index Fund Direct - Idcw

What is the current AUM of ICICI Prudential Nifty Pharma Index Fund Direct - Idcw?

As of Thu Jul 31, 2025, ICICI Prudential Nifty Pharma Index Fund Direct - Idcw manages assets worth ₹94.9 crore

How has ICICI Prudential Nifty Pharma Index Fund Direct - Idcw performed recently?

  • 3 Months: 0.71%
  • 6 Months: 11.47%

What is the long-term performance of ICICI Prudential Nifty Pharma Index Fund Direct - Idcw?

  • Since Inception: 21.13%

What is the portfolio composition of ICICI Prudential Nifty Pharma Index Fund Direct - Idcw?

Equity: 99.98%, Others: 0.02%.

Who manages ICICI Prudential Nifty Pharma Index Fund Direct - Idcw?

ICICI Prudential Nifty Pharma Index Fund Direct - Idcw is managed by Nishit Patel from ICICI Prudential Mutual Fund.

What is the market-cap allocation of ICICI Prudential Nifty Pharma Index Fund Direct - Idcw?

Large Cap: 69.38%, Mid Cap: 24.15%, Small Cap: 6.47%.

Which are the top companies ICICI Prudential Nifty Pharma Index Fund Direct - Idcw has invested in?

  • Sun Pharmaceutical Industries Ltd – 22.49% of the fund's portfolio
  • Sun Pharmaceutical Industries Ltd – 22.18% of the fund's portfolio
  • Sun Pharmaceutical Industries Ltd – 22.18% of the fund's portfolio
  • Sun Pharmaceutical Industries Ltd – 21.61% of the fund's portfolio
  • Cipla Ltd – 10.69% of the fund's portfolio

Which are the major sectors ICICI Prudential Nifty Pharma Index Fund Direct - Idcw focuses on?

  • Healthcare – 399.71% of the fund's portfolio
  • Unspecified – 0.29% of the fund's portfolio
View more FAQ's

Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.

Please consult your financial advisor for an informed decision.

Past performance may not be indicative of future results.

The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.

Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.

Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.

For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.

For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.

Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved

^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.

Close
Download the Policybazaar app
to manage all your insurance needs.
INSTALL
Claude
top

Become a Crorepati

Invest ₹10K/Month & Get ₹1 Crore# Returns

Mobile +91
*T&C Applied.